Acerus Announces Closing of US$5 Million Secured Term Loan

Acerus Pharmaceuticals (TSX:ASP, OTCQB:ASPCF) has announced it has entered into a US$5 million subordinated secured term loan facility with First...

VIDEO — US vs. Canada Healthcare Systems: Is One Better?

INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...

VIDEO Round-Up BBHIC 2019

BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...

VIDEO — Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis

In this BBHIC interview, Acerus Pharmaceuticals CEO Ed Gudaitis explains why the company isn't directly pursuing the cannabis market.

BBHIC 2019, Day 2: Notes From the Floor

The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.

Shares of Acerus Pharma Dip Amid Q4 and 2018 Financial Results

Shares of Acerus Pharmaceuticals dipped 7.14 percent on Tuesday following the release of its Q4 and fiscal 2018 financial results.

Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application

Acerus Pharmaceuticals (TSX:ASP) is today advising that it has received a Notice of Deficiency-Withdrawal Letter for its Gynoflor New Drug Submission....